These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3927838)

  • 1. Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.
    Yamada T; Nagata A; Ono Y; Suzuki Y; Yamanouchi T
    Antimicrob Agents Chemother; 1985 Jun; 27(6):921-4. PubMed ID: 3927838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis.
    Yamada T; Masuda K; Shoji K; Hori M
    J Bacteriol; 1972 Oct; 112(1):1-6. PubMed ID: 4342812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered ribosomes in antibiotic-resistant mutants of Mycobacterium smegmatis.
    Yamada T; Masuda K; Mizuguchi Y; Suga K
    Antimicrob Agents Chemother; 1976 May; 9(5):817-23. PubMed ID: 182073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK; Kanes W; Davidson PT; Moulding TS
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of rifampin on mycobacteria. I. Electron microscopic study of the effect of rifampin on Mycobacterium tuberculosis.
    Konno K; Oizumi K; Ariji F; Yamaguchi J; Oka S
    Am Rev Respir Dis; 1973 Jun; 107(6):1002-5. PubMed ID: 4197229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
    Bodmer T; Zürcher G; Imboden P; Telenti A
    J Antimicrob Chemother; 1995 Feb; 35(2):345-8. PubMed ID: 7759399
    [No Abstract]   [Full Text] [Related]  

  • 12. Few amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosis.
    Cummings MP; Segal MR
    BMC Bioinformatics; 2004 Sep; 5():137. PubMed ID: 15453919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.
    Mizuguchi Y; Suga K; Yamada T
    Microbiol Immunol; 1979; 23(7):595-604. PubMed ID: 228161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.
    Valim AR; Rossetti ML; Ribeiro MO; Zaha A
    J Clin Microbiol; 2000 Aug; 38(8):3119-22. PubMed ID: 10921994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
    Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 19. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.